Buy or sell Trace Genomics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Trace Genomics Stock
Advanced prevention and management of agricultural diseases.
About Trace Genomics Stock
Their molecular assay for soil and seed-borne pathogens enables affordable detection of hundreds of pathogens and beneficial organisms simultaneously. Their assay is based on genetic sequencing technology, enabling strain-specific identification and quantitation. They use artificial intelligence techniques used in fraud detection and data science to identify microbes and genetic mutations that cause or protect from disease, enabling data-driven insights into soil health and methods to increase crop quality, including yield and shelf life.
Funding History
July 2016 | $4.0M |
---|---|
February 2017 | $4.0M |
May 2018 | $14.9M |
May 2018 | $0 |
Management
Data Scientist
David Stone
Operations Manager
Lisa Becker
Co-Founder & President
Poornima Parameswaran
Microbiome Scientist
Jenna Lang
Co-Founder & CEO
Diane Wu
Senior Scientist
Scott Hickey
Press
FoodShot Global is digging up innovation for soil health as part of its first prize competition
TechCrunch - Jun, 6 2019
Trace Genomics launches a 23andMe for farms, raises $4 million to improve the world’s food supply
TechCrunch - Jul, 13 2016
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase